| Line Item | 2024-12-26 | Y/Y |
|---|---|---|
| Revenue | $240.8M | +45.8% |
| Cost of Revenue | $13.7M | +29.2% |
| R&D Expense | $3.3M | +10.0% |
| SG&A Expense | $50.7M | -11.5% |
| Operating Income | -$19.5M | +28.6% |
| Interest Expense | $1.7M | -93.9% |
| Pre-tax Income | -$22.1M | -103.2% |
| Income Tax | $200K | — |
| Net Income | -$22.3M |
| Line Item | 2024-12-26 | Y/Y |
|---|---|---|
| Cash & Equivalents | $75.1M | +117.1% |
| Short-term Investments | $100K | — |
| Accounts Receivable | $85.3M | -11.7% |
| Current Assets | $177.9M | +23.7% |
| Total Assets | $568.6M | +0.2% |
| Current Liabilities | $73.5M | +25.9% |
| Long-term Debt | $10.0M | +0.0% |
| Line Item | 2024-12-26 | Y/Y |
|---|---|---|
| Operating Cash Flow | $60.3M | +1000.0% |
| Capital Expenditures | $5.8M | +75.8% |
| Investing Cash Flow | -$5.7M | -117.5% |
| Financing Cash Flow | -$14.1M | +72.9% |
| Free Cash Flow | $54.5M | +645.0% |
| -103.2% |
| EPS (Basic) | -$0.23 | -101.6% |
| EPS (Diluted) | -$0.23 | -101.6% |
| Total Liabilities |
| $157.4M |
| +18.2% |
| Stockholders' Equity | $411.2M | -5.4% |